DAIVOBET

This brand name is authorized in Australia, Austria, Brazil, Croatia, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Israel, Lithuania, Malta, Mexico, New Zealand, Nigeria, Poland, Romania, Singapore, Spain, Tunisia.

Active ingredients

The drug DAIVOBET contains a combination of these active pharmaceutical ingredients (APIs):

1	Calcipotriol UNII 143NQ3779B - CALCIPOTRIENE
	Calcipotriol is a derivative of vitamin D for topical use on psoriasis. It probably works by suppressing keratinization. Advantage of substance or absence of odor and non-coloring of clothing.
	Read more about Calcipotriol
2	Betamethasone UNII 826Y60901U - BETAMETHASONE DIPROPIONATE
	Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.
	Read more about Betamethasone

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
DAIVOBET Gel	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
D05AX52	Calcipotriol, combinations	D Dermatologicals → D05 Antipsoriatics → D05A Antipsoriatics for topical use → D05AX Other antipsoriatics for topical use
Discover more medicines within D05AX52

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	10075G, 9494Q
BR	Câmara de Regulação do Mercado de Medicamentos	541112080000504, 541112090000603, 541112090000803, 541112090000903
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	28331-12-07, 360140512
EE	Ravimiamet	1093328, 1093339, 1093340, 1093351, 1093362, 1093373, 1534610, 1534621, 1534632, 1534643, 1616161, 1717242, 1717253
ES	Centro de información online de medicamentos de la AEMPS	64543, 70191
FI	Lääkealan turvallisuus- ja kehittämiskeskus	009810, 009843, 041516, 047114, 088705, 088714, 505807
FR	Base de données publique des médicaments	63931033, 68414260
HK	Department of Health Drug Office	50661
HR	Agencija za lijekove i medicinske proizvode	HR-H-414888118
IL	מִשְׂרַד הַבְּרִיאוּת	4703, 4704
LT	Valstybinė vaistų kontrolės tarnyba	1004143, 1010200, 1010201, 1061376, 1064028, 1064029, 1064030, 1065083, 1065084, 1065085, 1071357, 1074468, 1074469, 1079253, 1079254, 1080566
MT	Medicines Authority	MA024/00501
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	116M2012, 341M2004
NG	Registered Drug Product Database	B4-8503
NZ	Medicines and Medical Devices Safety Authority	11528, 14789
PL	Rejestru Produktów Leczniczych	100201534, 100272327, 100386380
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W56194001, W56194002, W56194003, W56194004, W56194005, W58498001, W58498002, W58498003, W58498004, W58498005, W58498006, W58498007, W58498008, W58498009
SG	Health Sciences Authority	12241P, 14318P
TN	Direction de la Pharmacie et du Médicament	5823064, 5823065, 5823066